Epithelial and neuroendocrine pancreatic tumors, while distinct in their morphological and genetic profiles, share common pathogenic mechanisms, including BRCA1 and BRCA2 gene mutations, impaired p53 function, and HIF-2α and mTOR receptor alterations. The gene discussed is EPAS1; the disease is pancreatic neuroendocrine tumor.